NCT05774574

Brief Summary

CBD may affect metabolic control and energy intake. However, there is currently little data regarding these specific outcomes in humans. Therefore, this study will investigate whether four weeks of supplementation with 60 mg/day CBD affects energy intake at a single meal, and or fasting blood-based markers of appetite regulation and metabolic health. Healthy, adult volunteers will be assigned to placebo or CBD supplementation, in a randomized controlled trial, comparing changes in outcomes across the supplementation period between groups.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 16, 2023

Completed
4 days until next milestone

Study Start

First participant enrolled

January 20, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 17, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 5, 2024

Completed
Last Updated

March 17, 2023

Status Verified

March 1, 2023

Enrollment Period

8 months

First QC Date

January 16, 2023

Last Update Submit

March 7, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Energy Intake

    Self-selected energy intake at an ad libitum mixed meal

    Baseline and after 4 weeks supplementation

Secondary Outcomes (9)

  • CBD

    Baseline and after 4 weeks supplementation

  • Liver transaminases

    Baseline and after 4 weeks supplementation

  • Hormones implicated in appetite regulation

    Baseline and after 4 weeks supplementation

  • Lipoproteins

    Baseline and after 4 weeks supplementation

  • Glucose

    Baseline and after 4 weeks supplementation

  • +4 more secondary outcomes

Study Arms (2)

CBD

EXPERIMENTAL

1 mL hemp oil containing 60 mg/mL CBD, daily.

Dietary Supplement: Cannabidiol (CBD) supplementation

Placebo

PLACEBO COMPARATOR

1 mL hemp oil containing 0 mg/mL CBD, daily.

Dietary Supplement: Placebo supplementation

Interventions

Daily supplementation with 1 ml hemp oil containing 60 mg CBD, applied orally

CBD
Placebo supplementationDIETARY_SUPPLEMENT

Daily supplementation with 1 ml hemp oil containing 0 mg CBD, applied orally

Placebo

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may not qualify if:

  • No history of any substance abuse
  • Have used tobacco regularly (\>2x in a week) within the past 6 months
  • Are suffering from any condition that may affect study outcomes
  • Currently use any prescription or over-the-counter medications (except for hormonal contraception and simple painkillers)
  • Have given a standard blood donation within 30 days of screening
  • Are currently pregnant or lactating
  • Are allergic/intolerant to any ingredients in food items we provide during the study (relevant allergens: oats, milk)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Loughborough University

Loughborough, Leicestershire, LE113TU, United Kingdom

RECRUITING

MeSH Terms

Conditions

Appetitive Behavior

Interventions

CannabidiolDietary Supplements

Condition Hierarchy (Ancestors)

Behavior, AnimalBehavior

Intervention Hierarchy (Ancestors)

CannabinoidsTerpenesHydrocarbonsOrganic ChemicalsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Central Study Contacts

Lewis J James, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Double-blind
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Lecturer in Nutrition

Study Record Dates

First Submitted

January 16, 2023

First Posted

March 17, 2023

Study Start

January 20, 2023

Primary Completion

October 1, 2023

Study Completion

January 5, 2024

Last Updated

March 17, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will share

Individual data for study outcomes will be shared on the Loughborough University Research Repository

Time Frame
Permanently, after publication of study findings.

Locations